Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States.

Curtis JR, Xie F, Yang S, Danila MI, Owensby JK, Chen L.

J Rheumatol. 2019 Mar;46(3):237-244. doi: 10.3899/jrheum.180071. Epub 2018 Nov 15.

PMID:
30442830
2.

Genetic Influences on Susceptibility to Rheumatoid Arthritis in African-Americans.

Laufer VA, Tiwari HK, Reynolds RJ, Danila MI, Wang J, Edberg JC, Kimberly RP, Kottyan LC, Harley JB, Mikuls TR, Gregersen PK, Absher DM, Langefeld CD, Arnett DK, Louis Bridges S Jr.

Hum Mol Genet. 2018 Nov 13. doi: 10.1093/hmg/ddy395. [Epub ahead of print]

PMID:
30423114
3.

Improving drug adherence in osteoporosis: an update on more recent studies.

Jaleel A, Saag KG, Danila MI.

Ther Adv Musculoskelet Dis. 2018 Jul;10(7):141-149. doi: 10.1177/1759720X18785539. Epub 2018 Jul 10. Review.

4.

A Performing Arts Intervention Improves Cognitive Dysfunction in 50 Hospitalized Older Adults.

Danila MI, Melnick JA, Mudano A, Flood K, Booth K, Kirklin K, Saag KG.

Innov Aging. 2018 Jun;2(2):igy013. doi: 10.1093/geroni/igy013. Epub 2018 Jun 18.

5.

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.

Navarro-Millán I, Zinski A, Shurbaji S, Johnson B, Fraenkel L, Willig J, Danila MI, Yun H, Curtis JR, Safford MM.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):80-87. doi: 10.1002/acr.23580.

PMID:
29669191
6.

Age and fecal microbial strain-specific differences in patients with spondyloarthritis.

Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, Danila MI, Spencer CH, Punaro MG, Schikler K, Reiff A, Kumar R, Cron RQ, Morrow CD, Lefkowitz EJ.

Arthritis Res Ther. 2018 Jan 30;20(1):14. doi: 10.1186/s13075-018-1510-6.

7.

Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.

Danila MI, Outman RC, Rahn EJ, Mudano AS, Redden DT, Li P, Allison JJ, Anderson FA, Wyman A, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, Miller MJ, Curtis JR, Warriner AH, Wright NC, Saag KG.

J Bone Miner Res. 2018 May;33(5):763-772. doi: 10.1002/jbmr.3395. Epub 2018 Feb 26.

8.

CUILESS2016: a clinical corpus applying compositional normalization of text mentions.

Osborne JD, Neu MB, Danila MI, Solorio T, Bethard SJ.

J Biomed Semantics. 2018 Jan 10;9(1):2. doi: 10.1186/s13326-017-0173-6.

9.

Use of Scribes for Documentation Assistance in Rheumatology and Endocrinology Clinics: Impact on Clinic Workflow and Patient and Physician Satisfaction.

Danila MI, Melnick JA, Curtis JR, Menachemi N, Saag KG.

J Clin Rheumatol. 2018 Apr;24(3):116-121. doi: 10.1097/RHU.0000000000000620.

PMID:
29280815
10.

Advancing the Science and Practice of Medication Adherence.

Stirratt MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA.

J Gen Intern Med. 2018 Feb;33(2):216-222. doi: 10.1007/s11606-017-4198-4.

11.

Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.

Curtis JR, Chen L, Danila MI, Saag KG, Parham KL, Cush JJ.

J Rheumatol. 2018 Jan;45(1):40-44. doi: 10.3899/jrheum.170548. Epub 2017 Nov 15.

12.

Dense Genotyping of Immune-Related Regions Identifies Loci for Rheumatoid Arthritis Risk and Damage in African Americans.

Danila MI, Laufer VA, Reynolds RJ, Yan Q, Liu N, Gregersen PK, Lee A, Kern M, Langefeld CD, Arnett DK, Bridges SL Jr.

Mol Med. 2017 Sep;23:177-187. doi: 10.2119/molmed.2017.00081. Epub 2017 Jun 29.

13.

Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Wright NC, Foster PJ, Mudano AS, Melnick JA, Lewiecki EM, Shergy WJ, Curtis JR, Cutter GR, Danila MI, Kilgore ML, Lewis EC, Morgan SL, Redden DT, Warriner AH, Saag KG.

Osteoporos Int. 2017 Aug;28(8):2505. doi: 10.1007/s00198-017-4105-1. No abstract available.

PMID:
28593448
14.

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Wright NC, Foster PJ, Mudano AS, Melnick JA, Lewiecki EM, Shergy WJ, Curtis JR, Cutter GR, Danila MI, Kilgore ML, Lewis EC, Morgan SL, Redden DT, Warriner AH, Saag KG.

Osteoporos Int. 2017 Aug;28(8):2495-2503. doi: 10.1007/s00198-017-4073-5. Epub 2017 May 24. Erratum in: Osteoporos Int. 2017 Jun 7;:.

15.

Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.

Navarro-Millán I, Darrah E, Westfall AO, Mikuls TR, Reynolds RJ, Danila MI, Curtis JR; CLEAR Investigators, Rosen A, Bridges SL Jr.

Arthritis Res Ther. 2016 Oct 22;18(1):241.

16.

A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.

Danila MI, Outman RC, Rahn EJ, Mudano AS, Thomas TF, Redden DT, Allison JJ, Anderson FA, Anderson JP, Cram PM, Curtis JR, Fraenkel L, Greenspan SL, LaCroix AZ, Majumdar SR, Miller MJ, Nieves JW, Safford MM, Silverman SL, Siris ES, Solomon DH, Warriner AH, Watts NB, Yood RA, Saag KG.

Contemp Clin Trials Commun. 2016 Dec 15;4:14-24.

17.

Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents.

Curtis JR, Danila MI, Chen L, Chan B, Ehst B, Xie F, Winthrop KL, Yun H.

J Psoriasis Psoriatic Arthritis. 2016 Summer;1(3):128-137.

18.

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.

Wampler Muskardin T, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, Curtis JR, Danila MI, Cofield SS, Shadick N, Nigrovic PA, St Clair EW, Bingham CO 3rd, Furie R, Robinson W, Genovese M, Striebich CC, O'Dell JR, Thiele GM, Moreland LW, Levesque M, Bridges SL Jr, Gregersen PK, Niewold TB.

Ann Rheum Dis. 2016 Oct;75(10):1757-62. doi: 10.1136/annrheumdis-2015-208001. Epub 2015 Nov 6.

19.

The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.

Danila MI, Westfall AO, Raman K, Chen L, Reynolds RJ, Hughes LB, Arnett DK, McGwin G, Szalai AJ, van der Heijde DM, Conn D, Callahan LF, Moreland LW, Bridges SL Jr.

Genes Immun. 2015 Oct;16(7):446-51. doi: 10.1038/gene.2015.24. Epub 2015 Jul 30.

20.

Simple regression for correcting ΔCt bias in RT-qPCR low-density array data normalization.

Cui X, Yu S, Tamhane A, Causey ZL, Steg A, Danila MI, Reynolds RJ, Wang J, Wanzeck KC, Tang Q, Ledbetter SS, Redden DT, Johnson MR, Bridges SL Jr.

BMC Genomics. 2015 Feb 14;16:82. doi: 10.1186/s12864-015-1274-1.

21.

Expression of Interferon-γ Receptor Genes in Peripheral Blood Mononuclear Cells Is Associated With Rheumatoid Arthritis and Its Radiographic Severity in African Americans.

Tang Q, Danila MI, Cui X, Parks L, Baker BJ, Reynolds RJ, Raman C, Wanseck KC, Redden DT, Johnson MR; CLEAR Investigators, Bridges SL Jr.

Arthritis Rheumatol. 2015 May;67(5):1165-70. doi: 10.1002/art.39056.

22.

HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues.

Reynolds RJ, Ahmed AF, Danila MI, Hughes LB; Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis Investigators, Gregersen PK, Raychaudhuri S, Plenge RM, Bridges SL Jr.

Arthritis Rheumatol. 2014 Dec;66(12):3274-82. doi: 10.1002/art.38855.

23.

Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.

Aslibekyan S, Sha J, Redden DT, Moreland LW, O'Dell JR, Curtis JR, Mikuls TR, Reynolds RJ, Danila MI, Bridges SL Jr.

Ann Rheum Dis. 2014 Apr;73(4):785-6. doi: 10.1136/annrheumdis-2013-204263. Epub 2013 Nov 29. No abstract available.

24.

Ethnic-specific genetic analyses in rheumatoid arthritis: incremental gains but valuable contributions to the big picture.

Danila MI, Reynolds RJ, Tiwari HK, Bridges SL Jr.

Arthritis Rheum. 2013 Dec;65(12):3014-6. doi: 10.1002/art.38111. No abstract available.

25.

Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?

Halilova KI, Brown EE, Morgan SL, Bridges SL Jr, Hwang MH, Arnett DK, Danila MI.

Int J Rheumatol. 2012;2012:978396. doi: 10.1155/2012/978396. Epub 2012 Jul 9.

26.

Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?

Danila MI, Hughes LB, Brown EE, Morgan SL, Baggott JE, Arnett DK, Bridges SL Jr.

Curr Rheumatol Rep. 2010 Oct;12(5):342-7. doi: 10.1007/s11926-010-0120-3.

27.

Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study.

Bridges SL Jr, Causey ZL, Burgos PI, Huynh BQ, Hughes LB, Danila MI, van Everdingen A, Ledbetter S, Conn DL, Tamhane A, Westfall AO, Jonas BL, Callahan LF, Smith EA, Brasington R, Moreland LW, Alarcón GS, van der Heijde DM.

Arthritis Care Res (Hoboken). 2010 May;62(5):624-31. doi: 10.1002/acr.20040.

28.

Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis.

Burgos PI, Causey ZL, Tamhane A, Kelley JM, Brown EE, Hughes LB, Danila MI, van Everdingen A, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD Jr, Moreland LW, van der Heijde DM, Alarcón GS, Bridges SL Jr.

Arthritis Res Ther. 2010;12(3):R75. doi: 10.1186/ar2994. Epub 2010 May 5.

29.

Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.

Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR.

Spec Care Dentist. 2010 Mar-Apr;30(2):77-82. doi: 10.1111/j.1754-4505.2009.00128.x. Review.

30.

Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans.

Kelley JM, Hughes LB, Malik A, Danila MI, Edberg Y, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD, Edberg JC, Kimberly RP, Moreland LW, Bridges SL.

Ann Rheum Dis. 2010 Apr;69(4):625-6. doi: 10.1136/ard.2009.113183. No abstract available.

31.

Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans.

Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD Jr, Allison DB Jr, Kimberly RP, Moreland LW, Edberg JC, Bridges SL Jr.

PLoS Genet. 2009 Dec;5(12). doi: 10.1371/annotation/80bd7285-9d2d-403a-8e6f-9c375bf977ca. Epub 2009 Dec 1. No abstract available.

32.

Annotating the human genome with Disease Ontology.

Osborne JD, Flatow J, Holko M, Lin SM, Kibbe WA, Zhu LJ, Danila MI, Feng G, Chisholm RL.

BMC Genomics. 2009 Jul 7;10 Suppl 1:S6. doi: 10.1186/1471-2164-10-S1-S6.

33.

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Pons-Estel GJ, Alarcón GS, McGwin G Jr, Danila MI, Zhang J, Bastian HM, Reveille JD, Vilá LM; Lumina Study Group.

Arthritis Rheum. 2009 Jun 15;61(6):830-9. doi: 10.1002/art.24538.

34.

Understanding Personalized Medicine in Rheumatoid Arthritis: A Clinician's Guide to the Future.

Burgos PI, Danila MI, Kelley JM, Hughes LB, Bridges SL Jr.

Ther Adv Musculoskelet Dis. 2009 Apr;1(2):97-105. doi: 10.1177/1759720X09351778.

35.

An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans.

Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD, Allison DB, Kimberly RP, Moreland LW, Edberg JC, Bridges SL Jr.

PLoS Genet. 2009 Mar;5(3):e1000424. doi: 10.1371/journal.pgen.1000424. Epub 2009 Mar 20. Retraction in: Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD Jr, Allison DB Jr, Kimberly RP, Moreland LW, Edberg JC, Bridges SL Jr. PLoS Genet..

36.

Recent advances in personalizing rheumatoid arthritis therapy and management.

Hughes LB, Danila MI, Bridges SL.

Per Med. 2009 Mar;6(2):159-170. doi: 10.2217/17410541.6.2.159.

PMID:
29788606
37.

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Danila MI, Pons-Estel GJ, Zhang J, Vilá LM, Reveille JD, Alarcón GS.

Rheumatology (Oxford). 2009 May;48(5):542-5. doi: 10.1093/rheumatology/kep012. Epub 2009 Feb 20.

38.

Update on pathogenic mechanisms of systemic necrotizing vasculitis.

Danila MI, Bridges SL Jr.

Curr Rheumatol Rep. 2008 Dec;10(6):430-5. Review.

PMID:
19007531
39.

Pharmacogenetics of etanercept in rheumatoid arthritis.

Danila MI, Hughes LB, Bridges SL.

Pharmacogenomics. 2008 Aug;9(8):1011-5. doi: 10.2217/14622416.9.8.1011. Review.

40.

Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Danila MI, Patkar NM, Curtis JR, Saag KG, Teng GG.

Curr Opin Rheumatol. 2008 May;20(3):327-33. doi: 10.1097/BOR.0b013e3282fb03d8. Review.

41.

Tattoo: inflicted vasculitis?

Jolly M, Danila MI.

J Clin Rheumatol. 2007 Feb;13(1):49. No abstract available. Erratum in: J Clin Rheumatol. 2007 Apr;13(2):69. Danilla, Maria [corrected to Danila, Maria I].

PMID:
17278953
42.

The genomic sequence of ectromelia virus, the causative agent of mousepox.

Chen N, Danila MI, Feng Z, Buller RM, Wang C, Han X, Lefkowitz EJ, Upton C.

Virology. 2003 Dec 5;317(1):165-86.

Supplemental Content

Loading ...
Support Center